Related Experiment Video
Updated: Jan 10, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
The HALP Index as a Bridge Between Nutrition, Inflammation, and Coagulation in Predicting DVT Risk in Stroke
Siqi Zhang1,2, Shuangyang Niu1,2, Yonghui Wang2
1School of Nursing and Rehabilitation, Shandong University, Jinan, China.
The hemoglobin-albumin-lymphocyte-platelet (HALP) index predicts deep vein thrombosis (DVT) in stroke patients. Higher HALP scores are linked to lower DVT risk, suggesting its value in preventing DVT.
Area of Science:
- Biomedical Science
- Clinical Medicine
- Hematology
Background:
- The hemoglobin-albumin-lymphocyte-platelet (HALP) index integrates nutritional, inflammatory, and immune status.
- Its predictive role for deep vein thrombosis (DVT) in stroke patients is not well-established.
- The influence of HALP on coagulation biomarkers like D-dimer requires further investigation.
Purpose of the Study:
- To investigate the association between the HALP index and DVT occurrence in stroke patients.
- To explore HALP's potential role in moderating D-dimer levels and DVT formation.
- To assess HALP as a predictor for DVT in the stroke population.
Main Methods:
- Retrospective study of 611 stroke patients, categorized into HALP index quartiles.
- Multivariate logistic regression and restricted cubic spline (RCS) analysis were employed.
- Moderation analysis examined the interaction between HALP and D-dimer levels.
Main Results:
- Higher HALP index quartiles showed a significant inverse association with DVT occurrence (p < .001).
- RCS modeling indicated a threshold effect, with increased DVT risk below a HALP level of 33.5.
- HALP significantly moderated the association between D-dimer and DVT, particularly in males and overweight individuals.
Conclusions:
- The HALP index is a strong, independent predictor of post-stroke DVT.
- HALP plays a moderating role in the prothrombotic effects of D-dimer.
- The HALP index offers clinical utility for early DVT risk stratification and personalized prevention in stroke patients.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

